Ask AI
ASC4START
ASC4START: Phase IIIb Trial of Asciminib vs Nilotinib in Newly Diagnosed Ph+ Chronic-Phase Chronic Myeloid Leukemia

Released: June 06, 2025

Expiration: December 05, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 06, 2025

Expiration: December 05, 2025